Trial Profile
A trial of rebamipide for the healing of artificial ulcers after endoscopic submucosal dissection.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 15 Sep 2013
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary) ; Omeprazole
- Indications Gastric ulcer
- Focus Therapeutic Use
- 15 Sep 2013 New trial record